Inventor

DANGL MARKUS

DE1 patents

Patents

1 patent

US9657351B2May 23, 2017

MRNA-based gene expression for personalizing patient cancer therapy with an MDM2 antagonist

HOFFMANN LA ROCHE1 citations47